Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$773K Buy
2,667
+306
+13% +$83.3K 0.03% 448
2026
Q2
$837K Buy
2,361
+19
+0.8% +$5.05K 0.03% 435
2026
Q1
$354K Buy
2,342
+275
+13% +$33.4K 0.02% 649
2025
Q4
$226K Buy
2,067
+17
+0.8% +$2.47K 0.01% 817
2025
Q3
$290K Buy
2,050
+103
+5% +$15K 0.01% 683
2025
Q2
$315K Buy
+1,947
New +$242K 0.01% 636
2024
Q4
– Sell
-2,420
Closed -$346K – 889
2024
Q3
$346K Buy
2,420
+345
+17% +$49K 0.02% 618
2024
Q2
$340K Sell
2,075
-8,425
-80% -$1.05M 0.02% 592
2024
Q1
$1.31M Buy
+10,500
New +$1.11M 0.07% 248

Other funds holding ARM

Moors & Cabot's ARM Position: Q3 2026 in Review

Moors & Cabot increased its Arm (ARM) stake by 13% in Q3 2026, buying an estimated $83.3K and bringing the position to 2,667 shares worth $773K. The position accounts for 0.03% of the portfolio, ranked #448.

Moors & Cabot first reported a position in ARM in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.31M in Q1 2024. 526 funds tracked by Wall St. Rank hold ARM as of Q3 2026.

  • Moors & Cabot held 2,667 shares of Arm worth $773K as of Q3 2026.
  • Moors & Cabot bought 306 Arm shares in Q3 2026, an estimated $83.3K.
  • Arm made up 0.03% of Moors & Cabot's portfolio in Q3 2026, its #448 holding.
  • Moors & Cabot first reported a position in Arm in Q1 2024 and has held it in 9 quarters since.
  • Moors & Cabot's Arm position peaked at $1.31M in Q1 2024.
  • 526 funds tracked by Wall St. Rank held Arm as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.